Last updated on December 2019

A Study of BMS-813160 in Combination With Chemotherapy or Nivolumab in Patients With Advanced Solid Tumors

Brief description of study

This study will evaluate the safety profile, tolerability, PK, PD, and preliminary efficacy of BMS-813160 alone or in combination with either chemotherapy or nivolumab in participants with metastatic colorectal and pancreatic cancers.

Clinical Study Identifier: NCT03184870

Find a site near you

Start Over

University Hospitals Cleveland Medical Center

Cleveland, OH United States
  Connect »